These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 22364400)

  • 1. Persistence of stimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Palli SR; Kamble PS; Chen H; Aparasu RR
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):139-48. PubMed ID: 22364400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
    Barner JC; Khoza S; Oladapo A
    Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of concomitant use of antipsychotics and stimulants and its impact on stimulant persistence in pediatric attention deficit hyperactivity disorder.
    Bali V; Kamble PS; Aparasu RR
    J Manag Care Spec Pharm; 2015 Jun; 21(6):486-98. PubMed ID: 26011550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilization patterns of stimulants in ADHD in the Medicaid population: a retrospective analysis of data from the Texas Medicaid program.
    Lawson KA; Johnsrud M; Hodgkins P; Sasané R; Crismon ML
    Clin Ther; 2012 Apr; 34(4):944-956.e4. PubMed ID: 22444786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.
    Christensen L; Sasané R; Hodgkins P; Harley C; Tetali S
    Curr Med Res Opin; 2010 Apr; 26(4):977-89. PubMed ID: 20178404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications.
    Setyawan J; Guérin A; Hodgkins P; Gauthier G; Cloutier M; Wu E; Erder MH
    J Med Econ; 2013 Nov; 16(11):1275-89. PubMed ID: 24004347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adults.
    Setyawan J; Hodgkins P; Guérin A; Gauthier G; Cloutier M; Wu E; Erder MH
    J Med Econ; 2013 Oct; 16(10):1203-15. PubMed ID: 23937642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations.
    Molife C; Bernauer MJ; Farr AM; Haynes VS; Kelsey D
    Postgrad Med; 2012 Sep; 124(5):7-22. PubMed ID: 23095422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
    Marcus SC; Wan GJ; Kemner JE; Olfson M
    Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent use of stimulants and second-generation antipsychotics among children with ADHD enrolled in Medicaid.
    Kamble P; Chen H; Johnson ML; Bhatara V; Aparasu RR
    Psychiatr Serv; 2015 Apr; 66(4):404-10. PubMed ID: 25828983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of pharmacologic treatment in youths with attention deficit/hyperactivity disorder in Medicaid database.
    Winterstein AG; Gerhard T; Shuster J; Zito J; Johnson M; Liu H; Saidi A
    Ann Pharmacother; 2008 Jan; 42(1):24-31. PubMed ID: 18042808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of long-acting medications on attention-deficit/hyperactivity disorder treatment disparities.
    Saloner B; Fullerton C; McGuire T
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):401-9. PubMed ID: 23952187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
    Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
    J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes with methylphenidate formulations among patients with ADHD: retrospective claims analysis of a managed care population.
    Hodgkins P; Sasané R; Christensen L; Harley C; Liu F
    Curr Med Res Opin; 2011; 27 Suppl 2():53-62. PubMed ID: 21973231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment patterns, adherence, and persistence in ADHD: a Canadian perspective.
    Lachaine J; Beauchemin C; Sasane R; Hodgkins PS
    Postgrad Med; 2012 May; 124(3):139-48. PubMed ID: 22691908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database.
    Bhang SY; Hwang JW; Kwak YS; Joung YS; Lee S; Kim B; Sohn SH; Chung US; Yang J; Hong M; Bahn GH; Choi HY; Oh IH; Lee YJ
    J Korean Med Sci; 2016 Aug; 31(8):1284-91. PubMed ID: 27478341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis.
    Setyawan J; Hodgkins P; Guérin A; Gauthier G; Cloutier M; Wu EQ; Erder MH
    J Med Econ; 2013 Jul; 16(7):962-75. PubMed ID: 23621503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal Trends in the Diagnosis of Attention-Deficit/Hyperactivity Disorder and Stimulant Use in Preschool Children on Medicaid.
    Davis DW; Feygin Y; Creel L; Williams PG; Lohr WD; Jones VF; Le J; Pasquenza N; Ghosal S; Jawad K; Yan X; Liu G; McKinley S
    J Pediatr; 2019 Apr; 207():185-191.e1. PubMed ID: 30545564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication persistence in Turkish children and adolescents with attention-deficit/hyperactivity disorder.
    Ayaz M; Ayaz AB; Soylu N; Yüksel S
    J Child Adolesc Psychopharmacol; 2014 Oct; 24(8):442-7. PubMed ID: 25010598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.